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ABSTRACT 
Leukotriene C4 is produced during hypoxic pul- 
monary vasoconstriction and leukotriene inhibitors 
preferentially inhibit the hypoxic pressor response in 
rats. If lipoxygenase products are important in 
hypoxic vasoconstriction, then an animal deficient in 
arachidonic acid should have a blunted hypoxic pressor 
response. We investigated if vascular responsiveness 
was decreased in vascular rings and isolated perfused 
lungs from rats raised on an essential fatty acid 
deficient diet (EFAD) compared to rats raised on a 
normal diet. Rats raised on the EFAD diet had 
decreased esterified plasma arachidonic acid and 
increased 5-, 8-, ll- eicosatrienoic acid compared to 
rats raised on the normal diet (control). Compared to 
the time matched responses in control isolated perfused 
lungs the pressor responses to angiotensin II and 
alveolar hypoxia were blunted in lungs from the arach- 
idonate deficient rats. This decreased pulmonary 
vascular responsiveness was not affected by the ad- 
dition of indomethacin or arachidonic acid to the lung 
perfusate. Similarly, the pulmonary artery rings from 
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arachidonate deficient rats demonstrated decreased 
reactivity to norepinephrine compared to rings from 
control rats. In contrast, the tension increases to 
norepinephrine were greater in aortic rings from the 
arachidonate deficient rats compared to control. Stim- 
ulated lung tissue from the arachidonate deficient 
animals produced less slow reacting substance and 
platelet activating factor like material but the same 
amount of 6-keto-PGFla and TXB2 compared to control 
lungs. Thus there is an association between altered 
vascular responsiveness and impairment of stimulated 
production of slow reacting substance and platelet 
activating factor like material in rats raised on an 
EFAD diet. 
INTRODUCTION 
Hypoxia causes vasoconstriction in the lung, but 
the mechanism by which it occurs remains unknown. One 
proposed mechanism is that alveolar hypoxia may elicit 
the release of a mediator substance from some lung 
cell. In the rat, leukotriene C4 is produced during 
hypoxic vasoconstriction (1) and in rats, sheep, and 
newborn lambs, but not in piglets, leukotriene inhibi- 
tors preferentially inhibit the hypoxic pressor 
response (2,3,4,5). We hypothesized that if lipox- 
ygenase products are important in hypoxic vasocon- 
striction, then an animal deficient in their substrate 
arachidonic acid should have a blunted hypoxic pressor 
response. 
Our approach was to examine whether vascular 
responsiveness was depressed in isolated perfused lungs 
and vascular rings from rats raised on an arachidonate 
deficient diet compared to rats raised on a normal 
diet. In addition, we examined whether the alteration 
in vascular responsiveness correlated with the lung 
production of cyclooxygenase metabolites 
6-keto-PGF I& 
(TXB2, 
lipoxygenase metabolites (slow-reacting 
substance- Ike material) and platelet activating 
factor-like material. The isolated perfused rat lung 
was used in part because in this system we could test 
whether the integrated pulmonary vascular response to 
alveolar hypoxia was preferentially inhibited in lungs 
from rats with a dietary deficiency of arachidonic 
acid. Vascular rings were used because in this system 
we could further assess if there was an alteration in 
pulmonary and/or systemic vascular reactivity secondary 
to the dietary deficiency of arachidonic acid. 
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METHODS 
Lungs or vessel rings were isolated from male 
Sprague-Dawley rats fed ablibitum either on a normal 
diet (Rat Chow) or on a vitamin supplemented essential 
fatty acid deficient diet (EFAD) (ICN Biochemical, 
Cleveland). Rats were started on this diet 3 weeks 
after birth and continued for 4-8 months. Rats were 
anesthetized with pentobarbitol (10 mg/kg ip). 
Preparation of vascular rings: The main pulmonary 
artery and thoracic aorta were removed (6) from rats 
raised on the normal and EFAD diet following the intra- 
cardiac injection of 500 units of heparin. After the 
vessels were cleaned of adherent fat and connective 
tissue, a ring 5 mm in width was separated from the 
remainder of the vessel. The vessel rings were con- 
nected to a Grass force transducer suspended in physio- 
logic salt solution bubbled with 21% 0 
7.35). Temperature was maintained i! 37-40°C. The 
and 5% CO2 (pH 
a 
vascular rings were equilibrated for 1 hour at a 
resting tension of 2 g (aorta) or 1.5 g (pulmonary 
artery) prior to the initiation of any intervention. 
Following the equilibration period, the bath concen- 
tration of KCL was increased to 80 mM and the resultant 
vessel tension development was recorded until a stable 
plateau occurred. The chamber was then flushed with 
fresh solution until tension returned to baseline. 
This process was repeated at pretensions varying from 1 
to 3 grams to determine the optimal pretension as 
judged by determining the maximal increase in tension 
to KCL. For a given ring all subsequent interventions 
were performed at this optimal pretension. In all 
rings, a dose-response to norepinephrine was estab- 
lished by increasi the bath co centration of nore- 
pinephrine (5 x 10 -V M to 5 x 10 -'M) and measuring the 
resultant increases in tension development. 
Preparation of isolated lungs: Lungs were iso- 
lated and perfused as previously described (2). Lungs 
were perfused at constant flow (.03 ml/g rat body 
weight/min) with physiologic salt solution osmotically 
stabilized with 4 g/100 ml of Ficoll (7). Mean pul- 
monary artery inflow pressure was measured with a 
Statham transducer and recorded on a Grass recorder. 
Perfusion pressure was proportional to pulmonary vas- 
cular resistance since the flow for a given lung was 
held constant. The lungs were ventilated via a 
tracheal cannula at a rate of 60 strokes/minute by a 
pressure-cycled Harvard animal ventilator with a posi- 
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tive end-expiratory pressure of 1 cm H 0. Lungs were 
ventilated with a normoxic (FIO 0.21) gas mixture 
containing 5% C02. The lungs an 
d?B 
erfusate reservoir 
were kept at a temperature of 37-40 C. The lungs were 
perfused for 30 minutes to reach a stable perfusion 
pressure and temperature prior to initiation of the 
experimental protocols. 
Three sequential series of pressor responses to 
intra-arterial angiotensin II followed by alveolar 
hypoxia were elicted. Five minutes were allowed for 
recovery or return of perfusion pressure to baseline 
between angiotensin II and hypoxic pressor responses. 
Pressor responses to angiotensin II were elicited by 
close arterial bolus injection of 0.05 ug dissolved in 
50 ul of normal saline. Alveolar hypoxia was induced 
by ventilating the lung with a gas mixture of 0% 02, 5% 
co 
z 
and 95% N2 for 4 minutes. The resultant lung 
ef luent PO2 was 46 f 5 mmHg. The plateau of the 
pressor response to alveolar hypoxia occurred within 
the period of the hypoxic exposure. In a separate 
series of lungs from rats raised on the EFAD diet, 
indomethacin (5 ug/ml of perfusate), was added to the 
lung perfusate at the onset of lung perfusion to inhi- 
bit prostaglandin and thromboxane synthesis. Also in 
these lungs, twenty minutes prior to the third angio- 
tensin II pressor response, arachidonic acid (1 ug, 
Nuchek) was also added to the lung perfusate as a bolus 
injection. 
Measurement of arachidonate metabolites and 
platelet activating factor-like activity: To assess 
cyclooxygenase metabolite production in rats raised on 
the normal and EFAD diet, 2 ml of lung perfusate was 
collected from each isolated lung preparation before 
and after the first angiotensin II pressor response. 
The samples were placed in tubes containing 20 ug of 
indomethacin to prevent the formation of cyclooxygenase 
metabolites following sample collection. Samples were 
frozen until they were subsequently analyzed by radio- 
immunoassay (8) for 6-keto-PGFla and TXB2. 
Slow-reacting substance (SRS)-like activity and 
platelet activating factor (PAF) -like activity were 
assessed in lung tissue obtained from the isolated lung 
preparations used above. Following the last hypoxic 
pressor response, the lungs were weighed following 
separation from the heart and other attached 
structures. The lung tissue was chopped and then 
incubated in physiologic salt solution containing 
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calcium ionophore (10 uM) for 30 minutes. An ethanol 
precipitated supernatant was dried in a rotary 
evaporator, subjected to XAD-7 separation, and then 
resuspended in 2 ml of 30% methanol in water. Aliquots 
of this product were then used to bioassay for SRS-like 
myotropic activity and PAF-like activity. 
Bioassay for SRS-like myotropic activity was 
performed using an isolated guinea pig ileum suspend:2 
in a 10 ml organ bath in the presence of atropine (10 
M) and pyrilamine (10m6 M) as previously described 
(119). Contractions were considered to be indicative 
of SRS-like myotropic activity if they met the fol- 
lowing criteria: slow onset, prolonged duration, dose- 
dependence, and reversible by the leukotriene receptor 
antagonist FPL 55712 (9). In each case the assay organ 
was responsive to synthetic leukotriene C4 (1 ng) 
before and after sample testing. 
Bioassay for PAF-like activity was carried out 
after passing the sample through a silicic acid 
column. Briefly, following the last step of a Bligh- 
Dyer extraction (lo), the sample was loaded onto a 
silicic acid column in a 95:s chloroform methanol 
mixture. The column was then sequentially washed with 
various mixtures of solvents. The effluent from washes 
with 95:s and 80:20 chloroform: methanol mixtures and 
100% methanol were discarded. The effluents from 
subsequent washes with 70:30 methanol:water were 
collected and subjected to a second Bligh-Dyer lipid 
extraction. The final sample was resuspended in Krebs- 
Ringer phosphate dextrose buffer with 0.25% nonpyro- 
genie human serum albumin (Miles Scientific). Aliquots 
of this final sample were used for the PAF assay. 
Bioassay for PAF was performed by measuring the 
release of H3-serotonin from rabbit platelets as 
previously described (11). Briefly, blood was col- 
lected from the central ear artery of New Zealand white 
rabbits into a 1:7 volume of acid citrate dextrose and 
centrifuged at 300 x g for 20 minutes. A pool of the 
resultant platelet-rich plasma was then incubated for 
30 minutes with 1 uCi of H3-serotonin binoxalate (New 
England Nuclear, Boston, MA) at 37°C. The platelets 
were sedimented at 2500 x g for 15 minutes and washed 
in Tyrode's gelatin without calcium in the presence of 
0.1 mM ethyleneglycoltetraacetic acid (EGTA). The 
platelets were again pelleted and washed in Tyrode's 
gelatin without calcium (no EGTA). After a final 
centrifugation, the platelets were resuspended in 




elatin without calcium to a concentration of 
1.25 x 10 (determined by absorbance at 530 nm). Each 
reaction tube contained various dilutions of the sample 
to be assayed in 450 ul volume of Tyrode's gelatin with 
calcium to which 50 ul of the platelet preparation was 
added. After 90 seconds of incubation at room temper- 
ature, the reaction was stopped by the addition of 20 
ul of 9% formaldehyde. Following centrifugation at 
2500 x g for 15 minutes, 100 ul of the supernatant was 
removed into 3 ml of scintillant (Scintiverse II, 
Fisher Scientific). The samples were counted for 
radioactivity in a liquid scintillation counter (model 
8000, Bechman Instruments, Fullerton, CA). The 
reported cpms were converted to dpms using the H number 
and a quench curve generated specifically for the scin- 
tillant, vials and buffer employed in this assay. The 
platelets in one reaction tube containing only buffer 
and platelets were lysed by Triton X-100 and were 
counted to determine the maximal radioactivity in this 
batch of platelets. The bioactivity in each sample was 
expressed as a percentage of this maximal radioacti- 
vity. The bioactivity in each sample was reported in 
ng-equivalent of PAF after comparison with a standard 
curve of serotonin-release elicited by known amounts of 
synthetic hexadecyl PAF (Bachem Chemicals, Bubendorf, 
Switzerland). In four samples, addition of a known 
amount of synthetic PAF prior to the purification 
process resulted in recovery rates ranging from 85 to 
95%. Thus, values for PAF are here reported without 
correction for recovery. 
Polyenoic fatty acid analysis: Ten ul of rat 
plasma was transesterified to the methyl esters by 
heating in methanol (8% in HCl) at 60°C for one hour. 
The methyl esters were then analyzed by reverse-phase 
high performance liquid chromatography utilizing an IBM 
Instruments Company C-18 column, with a mobile phase of 
10% methanol in water. The flow rate was 1 ml/min and 
the eluate was monitored for absorption at 214 nm. 
Arachidonic (20:4), and 5-,8-, ll- eicosatrienoic 
(20:3, Mead Acid) eluted at 18.3 and 27.1 minutes 
respectively. Arachidonic acid and Mead acid were 
quantitated externally by comparison to standard curves 
(12). Arachidonic acid and Mead acid were expressed as 
ng/ul of plasma. The analyses were in complete 
agreement with gas chromatographic analysis. 
Statistics Values are expressed as mean f SEM. 
Paired t-tests were used when responses in the same 
lung were compared. One-way analysis of variance was 
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used when multiple groups were compared. Multiple 
comparisons were made by the Student-Newman-Keul 
test. Dose response curves to norepinephrine were 
compared by two factor fixed effect two way analysis of 
variance concluding with contrasts. A p < 0.05 was 
accepted as significant. 
RESULTS 
Effect of EFAD diet on rat body weight and plasma 
polyenoic fatty acid composition: Rats raised on the 
EFAD diet (n = 16) tended to have lower body weights 
(384 f 25 g) compared to rats raised on the normal diet 
(453 f. 33 g, n = 8, p = 0.11). Plasma from rats raised 
on the EFAD diet (n = 14) had 16 + 3% (54 + 12 ng/ul) 
of the mean amount of arachidonic acid found in the 
plasma of rats raised on the normal diet (336 + 55 
ng/ul; n = 7). In contrast, 5-, 8-, ll-eicosatrienoate 
was present in the plasma (660 f 80 ng/ul) of the rats 
raised on the EFAD diet but was below (< 1 ng/ul) the 
level of detection in plasma from rats raised on the 
normal diet. 
Effect of EFAD diet on pulmonary vascular respon- 
siveness in isolated perfused lungs: Baseline mean 
pulmonary artery perfusion (PA) pressure was not dif- 
ferent (p = NS) in lungs from rats raised on the EFAD 
diet (6.5 + 0.6, n=12) compared to lungs from rats 
raised on a normal diet (5.5 f 0.6, n=4). The second 
hypoxic challenge caused PA pressure to increase 7.9 + 
0.6 mmHg in lungs from rats raised on the normal 
diet. The magnitude of the time-matched pressor 
response to alveolar hypoxia was less (p < 0.05) in 
lungs from rats raised on the EFAD diet (Table 1). 
This inhibition of the hypoxic pressor response in 
lungs from rats raised on the EFAD diet was not 
reversed by adding either indomethacin (5 ug/ml of 
perfusate) or indomethacin plus arachidonic acid (1 ug) 
to the lung perfusate approximately 45 minutes prior to 
the hypoxic challenge (Table 1). 
Compared to the time-matched response in control 
lungs, the magnitude of the PA pressor response to 
angiotensin II (0.05 ug) was less (p < 0.05) in lungs 
from rats raised on the EFAD diet (Table 1). As with 
the hypoxic pressor response, the inhibition of the 
angiotensin II pressor response in lungs from rats 
raised on the EFAD diet was not reversed by adding 
either indomethacin or indomethacin plus arachidonic 
acid to the lung perfusate approximately 40 minutes 
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z Pressor Responses (mmHg) 
Alveolar Angiotensin 
Hypoxia II - 
7.9 f 0.6 8.8 + 0.8 
4.3 f 0.7*b 4.0 + 0.9* 




+ Arachidonic Acid 4 5.5 + 0.5* 3.3 * 0.9* 
;: 
n = number of animals 
*= p < 0.05 compared to control 
Effect of an EFAD diet on pulmonary and systemic 
vascular reactivity in vessel rings: The maximum 
increase in tension to 80 mM KC1 tended to be less 
(p = 0.08) in the pulmonary artery rings from rats 
raised on an EFAD diet (0.9 f 0.2 g, n=4) compared to 
controls (1.6 + 0.2 g, n=4). A dose-response curve to 
norepinephrine showed decreased reactivity (p < 0.05) 
in the pulmonary artery rings from the rats raised on 
the EFAD diet (Figures 1 and 2). In contrast, 
reactivity to norepinephrine (Figure 2) was increased 
(p < 0.05) in aortic rings from rats raised on the EFAD 
diet compared to controls. 
Effects of EFAD diet on lipid mediator pro- 
duction: Typical SRS-like myotropic activity was 
present in calcium ionophore stimulated lung homogenate 
in all of the lungs tested (n = 4) from rats raised on 
the normal diet. A typical response is shown in Figure 
3. For each lung homogenate from rats raised on the 




Tension 1 cj 
Figure 1: Typical tracing showing increases in tension 
development by pulmonary artery rings from rats raised 
on the essential fatty acid deficient (top tracing) and 
normal (bottom tracing) diet in response to norepin- 
ephrine. Upward arrows indicate an incr ase in ba h 
concent ation of norepinephrine to 5 x 10 -5 -itI ,5x10 , 
5 x 10 --5 and 10s6 M, respectively. 
normal diet, 25 ul of the lung homogenate (total sample 
2 ml) produced SRS-like contractions on the guinea pig 
ileum (Figure 4). In contrast, in none of the rats 
raised on the EFAD diet did 25 ul of the lung homo- 
genate (total sample 2 ml) produce SRS-like contrac- 
tions on the guinea pig ileum (Figure 4). However, 
larger aliquots from lung homogenates from rats raised 
on the EFAD diet did demonstrate SRS-like myotropic 
activity in six of the eight lung homogenates tested 
(Figure 4). 
Platelet activating factor-like bioactivity was 
also decreased (p < 0.05) in calcium ionophore stimu- 
lated lung homogenate from rats raised on the EFAD diet 
(28 + 6 rig/g lung, n = 8) compared to lung homogenate 
from rats raised on the normal diet (65 ?r 9 rig/g lung, 
n = 4). 
Baseline levels of 6-keto-PGFla and TXB2, as well 
as the respective levels following an angiotensin II 
pressor response were not different (p = NS) in lung 
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Figure 2: Tension development in response to norepin- 
ephrine in vascular rings from rats raised on the 
normal (control) and essential fatty acid-deficient 
diet. 
effluent from lungs isolated from rats raised on the 
normal or EFAD diet (Table 2). Addition of indome- 
thacin to the lung perfusate of lungs from rats raised 
on the EFAD diet did inhibit (p < 0.05) the production 
of 6-keto-PGFla and TXB2 (Table 2). In these same 
lungs, and as expected, the addition of arachidonic 
acid to the lung perfusate did not reverse the 
inhibition of the production of 6-keto-PGFla and TXB2 
caused by indomethacin. 
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Tension 1 g 
2 min 
LTC4 2 ng 10 ul 25 ul 
CONTROL 
Figure 3: Contractile responses of the guinea pig 
ileum to exogenous LTC4 and to material extracted from 
whole lung homogenate stimulated by calcium ionophore 
from a rat raised on a normal diet. Time scale and 
magnitude of contraction are shown. 
TABLE 2 
CYCLOOXYGENASE METABOLITE PRODUCTION IN EFFLUENT FROM 
ISOLATED LUNGS IN RESPONSE TO ANGIOTENSIN II 





CONTROLb _--_--- 4 4.7 + 1.7d 194 f 82e 
EFADC NONE 8 7.2 f 2.4d 122 + 33e 
EFAD INDOMETHACIN 4 0.2 f o.o7*f 10 + 3* 
EFAD INDOMETHACIN + 4 0.1 + 0.01* 13 zk 3* 
ARACHIDONIC ACID 
;: 
n = number of rats. 
= Control refers to rats raised on a normal diet. 
C = EFAD refers to rats raised on the essential fatty 
acid deficient diet. 
d - Baseline levels for the control and EFAD groups 
were 5.4 + 2.0 ng/ml and 8.2 f 2.8 ng/ml respectively. 
e - Baseline levels for the control and EFAD groups 
were 77 f 26 and 92 f 24 respectively. 
f *= p < 0.05 compared to control 
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Figure 4: Amount of lung homogenate extract from rats 
raised on the normal (control) and essential fatty 
acid-deficient (EFAD) diet required to produce SRS-like 
myotropic activity on the guinea pig ileum. The homo- 
genates were stimulated with calcium ionophore. 
Numbers above data points indicate number of lung homo- 
genates demonstrating SRS-like myotropic activity 
(number above diagonal line) and total number of lung 
homogenates tested (number below diagonal line). 
DISCUSSION 
In this study we demonstrated in plasma from rats 
raised on the EFAD diet that there was a decreased 
level of arachidonic acid, the precursor for the pro- 
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duction of prostaglandins, thromboxane, and leuko- 
trienes. As expected, in essential fatty acid defi- 
ciency (13) an increased level of 5-, 8-, ll- eicosa- 
trienoic acid and a tendency for decreased weight gain 
were observed. 
The main finding of this study was that both 
hypoxic pulmonary vasoconstriction and calcium iono- 
phore stimulated lung production of SRS-like material 
were inhibited in lungs isolated from rats with 
decreased plasma levels of arachidonic acid. This 
inhibition of SRS production and hypoxic vasocon- 
striction is consistent with the hypothesis that 
lipoxygenase products of arachidonic acid may have a 
role in the mediation of hypoxic pulmonary 
vasoconstriction in isolated rat lungs. Although we 
did not demonstrate in the current study that there was 
an alteration in hypoxia-induced SRS production, we 
have previously demonstrated in isolated perfused rat 
lungs that leukotriene C4 is produced in response to 
acute alveolar hypoxia and that both leukotriene C4 
production and hypoxic pulmonary vasoconstriction were 
inhibited by leukotriene synthesis blockers (1,2). 
Similarly, previous work has demonstrated that chronic 
alveolar hypoxia caused pulmonary hypertension and 
production of SRS-like material in the intact rat 
(14). The pulmonary hypertension and SRS production 
were inhibited by pretreatment with a leukotriene 
synthesis blocker (14). If leukotrienes mediate 
hypoxic pulmonary vasoconstriction, then inhibition of 
their synthesis should inhibit vasoconstriction 
secondary to alveolar hypoxia but not vasoconstriction 
to other agonists. Previous studies (2,3,4) have 
demonstrated that inhibitors of leukotriene synthesis 
or action inhibit hypoxic pulmonary vasoconstriction 
without causing a nonspecific decrease in pulmonary 
vascular responsiveness. However, in the current study 
there was not a preferential inhibition of hypoxic 
pulmonary vasoconstriction, since in lungs isolated 
from rats raised on the EFAD diet both the pressor 
responses to hypoxia and angiotensin II were similarly 
inhibited. This nonspecific decrease in pulmonary 
vascular responsiveness was confirmed in isolated 
pulmonary artery rings from rats raised on the EFAD 
diet where there was decreased reactivity to 
norepinephrine induced vasoconstriction. 
This nonselective decrease in pulmonary vascular 
responsiveness could have been due to decreased pro- 
duction of SRS-like material in lung parenchyma or 
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vascular tissue from rats raised on the EFAD diet. 
Despite the potential of lungs from the arachidonate- 
deficient rats to produce LTC 
SRS-like myotropic activity (1 % 
and LTC5, which possess 
,16), the EFAD diet must 
have resulted in the production of less leukotrienes of 
the 3, 4, and 5 series since less SRS-like myotropic 
activity was detected by bioassay. Because of the 
decrease in plasma arachidonic acid one might expect 
decreased production of LTC4, D and E 
'dt'* sk,"od"r'o"d%:: mechanism responsible for inhibi ion of 
in our experiments is unclear. Stenson (13) has shown 
that a metabolite of 5-, 8-, ll- eicosatrienoic acid 
may inhibit LTA 
% 
hydrolase and LTB4 production. Thus, 
metabolites pro uced in response to the EFAD diet could 
possibly inhibit SRS production. The inability of 
exogenous arachidonic acid to restore pulmonary 
vascular responsiveness to control levels would be 
consistent with the presence of an inhibitory 
substance. However, the failure of exogenous arachi- 
donic acid to restore pulmonary vascular responsiveness 
could also be due to other factors. Time allowed for 
arachidonic acid incorporation, the amount supplied, or 
pools with different affinities for exogenous arachi- 
donic acid all could explain this finding. 
Cyclooxygenase metabolite production as assessed 
by production of 6-keto-PGFla and TXB 
to be involved in the decreased ? 
did not appear 
pu monary vascular 
responsiveness. A surprising finding was the lack of 
inhibition of prostacyclin and thromboxane production 
in lungs from rats raised on the EFAD diet. High 
baseline values for these metabolites in all lung ef- 
fluents likely represents activation of the cyclooxy- 
genase system due to the artificial circulation and 
ventilation. However, continued prostacyclin pro- 
duction did not explain the decrease in pulmonary 
vascular responsiveness since cylooxygenase inhibition 
by indomethacin did not reverse the decrease in pulmo- 
nary vascular responsiveness. The reason for the lack 
of inhibition of 6-keto-PGFlo and TXBZ production in 
lungs from rats raised on the EFAD diet is unclear, but 
this finding indicates a more complex relationship 
between substrate and arachidonic acid products. If 
there were different arachidonic acid pools conceivably 
dietary manipulation could affect these pools dif- 
ferently. 
Since in our study the EFAD diet led to decreased 
production of SRS and PAF-like material after calcium 
ionophore stimulation but did not affect 6-keto-PGFla 




production in the isolated lung, one might 
specula e that the EFAD diet affected the availability 
of phospholipids released from a pool from which both 
PAF and lipoxygenase products originate but not the 
pool from which prostaglandins are derived. That 
leukotrienes and PAF share a common precursor phospho- 
lipid (possibly l-O-alkyl-2-arachidonyl-sn-glycero-3- 
phosphocholine) has also been suggested in studies of 
neutrophils derived from EFAD rats. In these studies, 
neutrophils depleted of arachidonic acid did not synth- 
esize PAF or leukotrienes (17). Alternatively, inhibi- 
tion of PAF synthesis in the EFAD lungs could be merely 
a consequence of inhibition of leukotriene synthesis 
since LTC4 is known to stimulate PAF production (7). 
Although there is an association between altered 
vascular reactivity and impairment of stimulated pro- 
duction of SRS and PAF like material in the EFAD rat 
lungs, it has not been established that these two 
findings are causally related. One alternative pos- 
sibility is that the EFAD diet may have altered mem- 
brane permeability to calcium (18) or membrane fluidity 
by altering the lipid composition of vascular mem- 
branes. Finally, the tendency for decreased weight 
gain in rats raised on the EFAD diet does not seem to 
account for the decreased pulmonary vascular reacti- 
vity, because the difference in weight was small and 
less than that reported to inhibit pulmonary changes 
due to alveolar hypoxia (14,19). Furthermore, the 
finding of increased systemic vascular responsiveness 
in aortic rings from rats raised on the EFAD diet makes 
a general depression of vasoreactivity due to impaired 
weight gain unlikely. 
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